IRIS PubliCatt

Caira, Morena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.334
NA - Nord America 2.215
AS - Asia 572
AF - Africa 11
OC - Oceania 7
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.148
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.190
DE - Germania 1.869
CN - Cina 404
SE - Svezia 361
UA - Ucraina 329
PL - Polonia 150
FR - Francia 127
GB - Regno Unito 123
IT - Italia 109
IE - Irlanda 107
FI - Finlandia 64
SG - Singapore 63
RU - Federazione Russa 54
IN - India 46
TR - Turchia 36
MX - Messico 19
BE - Belgio 10
JP - Giappone 9
NL - Olanda 7
AU - Australia 5
CA - Canada 5
CI - Costa d'Avorio 5
ES - Italia 4
HK - Hong Kong 4
HU - Ungheria 4
BR - Brasile 3
CH - Svizzera 3
CL - Cile 3
NG - Nigeria 3
CZ - Repubblica Ceca 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LT - Lituania 2
NZ - Nuova Zelanda 2
RO - Romania 2
VN - Vietnam 2
ZA - Sudafrica 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
KR - Corea 1
KZ - Kazakistan 1
ME - Montenegro 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 6.148
Salva come PNG Salva come JPEG
Città #
Chandler 474
Jacksonville 194
Ashburn 145
San Mateo 145
Warsaw 143
Nürnberg 120
Dublin 106
Ann Arbor 102
Dearborn 94
Nanjing 91
Woodbridge 76
Wilmington 72
New York 64
Bremen 63
Lawrence 56
Boston 48
Houston 45
Singapore 45
Moscow 42
Nanchang 40
Zhengzhou 39
Munich 35
Izmir 33
Fairfield 31
Milan 31
Seattle 31
Marseille 30
Beijing 26
Lancaster 25
Kunming 24
University Park 22
Hebei 20
Tianjin 20
Shenyang 19
Redwood City 18
Mountain View 17
Boardman 15
Jiaxing 15
Los Angeles 15
Changsha 14
Cuauhtémoc 14
Shanghai 14
Philadelphia 13
Leawood 12
Brussels 10
Cambridge 10
Hangzhou 10
Auburn Hills 8
Fremont 8
Hefei 8
Pune 8
Costa Mesa 7
Guangzhou 7
Kraków 7
Norwalk 7
Princeton 7
Cattolica 6
Abidjan 5
Indiana 5
Jinan 5
Phoenix 5
Rome 5
Taizhou 5
Augusta 4
Budapest 4
Chicago 4
Henderson 4
Hong Kong 4
Lanzhou 4
Modena 4
Simi Valley 4
Amsterdam 3
Andover 3
Changchun 3
Edinburgh 3
Mcallen 3
Mexico City 3
Monmouth Junction 3
Ningbo 3
San Diego 3
Auckland 2
Bern 2
Bryanston 2
Canberra 2
Catania 2
Ercolano 2
Florence 2
London 2
Madrid 2
Pesaro 2
Quzhou 2
Rio Saliceto 2
San Francisco 2
San Jose 2
Stockholm 2
Tappahannock 2
Tokyo 2
Adelaide 1
Almaty 1
Arco 1
Totale 2.927
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 333
Factors associated with mortality in bacteremic patients with haematologic malignancies 295
Factors associated with mortality in bacteremic patients with hematologic malignancies. 295
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 292
A prospective survey of febrile events in hematological malignancies 245
Factors associated with mortality in bacteremic patients with hematologic malignancies. 159
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 155
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 148
Increased production of gliotoxin is related to the formation of biofilm byAspergillus fumigatus: an immunological approach 133
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 129
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 128
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 120
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 120
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 112
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 108
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 106
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 101
A prospective survey of febrile events in hematological malignancies 95
A prospective survey of febrile events in hematological malignancies 94
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 94
A patient with acute myeloid leukemia and a solid mass in the colon. 93
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 93
Uncommon yeast infections in hematological patients: from diagnosis to treatment 91
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 90
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 89
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 89
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 88
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 85
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 85
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 85
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 85
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 84
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 84
Advanced mast cell disease: an Italian Hematological Multicenter experience. 83
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 83
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 81
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 81
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 76
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 75
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 74
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 72
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 69
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 69
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 68
The role of primary antifungal prophylaxis in patients with haematological malignancies 66
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 66
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 65
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 65
. Pulmonary aspergillosis: lights and shadows 54
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 54
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 54
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 54
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 52
Invasive fungal infections in patients with acute myeloid leukcemia and in those submitted to allogenic hemopoietic stem cell transplant: Who is at highest risk?. 51
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 51
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 50
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 47
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 42
The management of febrile neutropenia in the posaconazole era: a new challenge? 37
Risks for infection in patients with myelodysplasia and acute leukemia 36
Uncommon yeast infections in hematological patients: from diagnosis to treatment 35
Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends 33
Italian Hema e-Chart Group.Continuous surveillance of invasive fungal infection: a realistic goal for the near future. 32
Totale 6.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.071 181 107 48 91 79 118 112 41 73 52 91 78
2020/2021633 16 71 12 69 94 38 89 16 74 18 126 10
2021/2022561 72 60 7 24 16 11 13 86 25 42 71 134
2022/20231.207 123 174 109 224 92 163 45 104 138 5 25 5
2023/2024439 32 155 6 8 14 70 33 8 4 9 62 38
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 6.178